ABUS Historical Earnings image   This ABUS historical earnings page last updated 8/8/2022
ABUS Historical Revenue
PeriodHistorical Earnings DateGAAP
Q2 20228/4/20220.01B
Q1 20225/5/20220.01B
Q4 20213/3/20220.00B
Q3 202111/4/20210.00B
Q2 20218/5/20210.00B
Q1 20215/5/20210.00B
Q4 20203/4/20210.00B
Q3 202011/5/20200.00B
Q2 20208/7/20200.00B
Q1 20205/11/20200.00B
Q4 20193/5/20200.00B
Q3 201911/6/20190.00B
Q2 20198/5/20190.00B
Q1 20195/6/20190.00B
Q4 20183/7/20191.60M
Q3 201811/7/20181.60M
Q2 20188/2/20181.20M
Q1 20185/3/20181.40M
Q4 20173/14/20182.50M
Q3 201711/2/20176.90M
Q2 20178/3/20171.00M
Q1 20175/4/2017200000
Q4 20163/21/2017-0.20M
Q3 201611/3/2016700000
Q2 20168/4/2016300000
Q1 20165/4/2016600000
Q4 20153/9/201612.70M
Q3 201511/5/20154.10M
Q2 20158/5/20153.40M
Q1 20155/6/20154.70M
Q4 20143/9/20154.40M
Q3 201411/14/20144.40M
Q2 20148/13/20141.96M
Q1 20145/14/20144.91M
Q4 20133/6/20140.00B
Q3 201311/13/20130.00B
Q2 20138/12/20130.00B
Q1 20135/14/20130.00B
Q4 20123/27/20133.89M
Q3 201211/13/20123.05B
ABUS Historical Earnings EPS
PeriodHistorical Earnings DateGAAP
Q2 20228/4/2022-0.100
Q1 20225/5/2022-0.110
Q4 20213/3/2022-0.150
Q3 202111/4/2021-0.240
Q2 20218/5/2021-0.230
Q1 20215/5/2021-0.210
Q4 20203/4/2021-0.230
Q3 202011/5/2020-0.270
Q2 20208/7/2020-0.250
Q1 20205/11/2020-0.250
Q4 20193/5/2020-0.460
Q3 201911/6/2019-0.730
Q2 20198/5/2019-0.460
Q1 20195/6/2019-0.470
Q4 20183/7/2019-0.37
Q3 201811/7/2018-0.3
Q2 20188/2/2018-0.44
Q1 20185/3/2018-0.36
Q4 20173/14/2018-0.35
Q3 201711/2/2017-0.17
Q2 20178/3/2017-0.28
Q1 20175/4/2017-0.29
Q4 20163/21/2017-0.38
Q3 201611/3/2016-0.31
Q2 20168/4/2016-0.35
Q1 20165/4/2016-0.19
Q4 20153/9/2016-0.07
Q3 201511/5/2015-0.31
Q2 20158/5/2015-0.2
Q1 20155/6/2015-0.36
Q4 20143/9/2015-0.27
Q3 201411/14/2014-0.39
Q2 20148/13/2014-0.31
Q1 20145/14/2014-0.93
Q4 20133/6/2014-0.100
Q3 201311/13/2013-0.420
Q2 20138/12/2013-0.220
Q1 20135/14/2013-0.18
Q4 20123/27/20132.81
Q3 201211/13/2012-0.25
Quotes delayed 20 minutes

Email EnvelopeFree ABUS Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Arbutus Biopharma (ABUS) is categorized under the Miscellaneous sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

ACHR Historical Earnings
ACN Historical Earnings
ADNT Historical Earnings
ADTH Historical Earnings
AEVA Historical Earnings
AFMD Historical Earnings
ALIT Historical Earnings
ALLE Historical Earnings
AMPS Historical Earnings
APTV Historical Earnings
What was the record high ABUS historical earnings result?
In terms of earnings or revenue, what is the best ABUS historical earnings result that Arbutus Biopharma has ever posted, and when?

✔️Accepted answer: Within our data set, the highest ABUS historical earnings result was set in Q4 2012, when Arbutus Biopharma posted results of 2.81/share. The most successful revenue quarter within our data set was Q3 2012 when Arbutus Biopharma reported revenue of 3.05B.

What was the lowest Arbutus Biopharma historical earnings result?
In terms of top line revenue or bottom line earnings per share, what was the lowest ABUS has reported, and when?

✔️Accepted answer: Within our data set, the lowest ABUS historical earnings result was set in Q1 2014, when Arbutus Biopharma posted results of -0.93/share. The smallest revenue quarter within our data set was Q4 2016 when Arbutus Biopharma reported revenue of -0.20M.

On this page we presented the ABUS historical earnings date information for Arbutus Biopharma. Reviewing that ABUS Historical Earnings for the company, we see that the highest historical earnings result in our data set was in Q4 2012, when ABUS posted gaap of 2.81/share. Meanwhile the lowest ABUS historical earnings result was in Q1 2014, when ABUS posted gaap of -0.93/share. Moving to Arbutus Biopharmas historical revenue numbers, the largest revenue quarter in our data set was seen in Q3 2012 when ABUS reported 3.05B in revenue, while the smallest revenue quarter was Q4 2016 when ABUS reported -0.20M in revenue.

For self directed investors doing their due diligence on ABUS or any other given stock, their research can benefit from looking into all of the Arbutus Biopharma historical earnings in our data set presented side by side on one page for ease of comparison. Reviewing this historical EPS information can help when projecting future earnings per share, as well as providing important context for pondering whether the historical earnings trajectory justifies the current stock value or not. That's why we bring you HistoricalEarnings.com to make it more convenient for investors to look into Arbutus Biopharma historical earnings, or the historical earnings information for any stock in our coverage universe. In your continued due diligence investigations, we hope you check out the further links included for historical PE studies, earnings surprises history as well as next earnings dates for ABUS. Thanks for visiting, and the next time you need to research ABUS historical earnings or those of another stock, we hope our site will come to your mind as your preferred historical earnings, revenue, and EPS research resource of choice.

Recommended: QLGN Videos, PBLA YTD Return, Top Ten Hedge Funds Holding SMP.

 

ABUS Historical Earnings | www.HistoricalEarnings.com | Copyright © 2020 - 2022, All Rights Reserved

Nothing in HistoricalEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.